Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
13.63 USD | -1.23% | -7.27% | +27.57% |
05-20 | Immunome Completes Purchase of Antibodies From Atreca | MT |
05-20 | Immunome, Inc. completed the acquisition of Substantially all Assets of Atreca, Inc.. | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.57% | 827M | |
+8.38% | 115B | |
+13.04% | 107B | |
-13.56% | 22.31B | |
-3.99% | 21.6B | |
-5.62% | 18.23B | |
-39.93% | 17.62B | |
+7.51% | 14.26B | |
+33.73% | 12.37B | |
-28.32% | 8.28B |
- Stock Market
- Equities
- IMNM Stock
- News Immunome, Inc.
- JPMorgan Starts Immunome With Overweight Rating, $24 Price Target